Lv1
70 积分 2024-01-29 加入
Toxicity-over-time analysis of anti-EGFR-based maintenance versus stop&go in left-sided, RAS/BRAF wild-type metastatic colorectal cancer
2个月前
已关闭
Trastuzumab deruxtecan: Redefining precision oncology across HER2-driven cancers
3个月前
已完结
Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2–Expressing Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer: A Multicenter, Open-Label, Phase I Trial
4个月前
已完结
Recurrence Prediction by Circulating Tumor DNA in the Patient with Colorectal Liver Metastases After Hepatectomy: A Prospective Biomarker Study
5个月前
已完结
Dynamic CtDNA monitoring in adjuvant therapy and recurrence for colorectal liver metastases (PKUCRLM-01): a prospective study
5个月前
已关闭
CFT1946 Is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader That Overcomes BRAF Inhibitor Resistance
6个月前
已完结
Emerging EGFR-Targeted Therapy in Head and Neck Cancer
6个月前
已完结
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials
7个月前
已完结
Treatment and Management of Peritoneal Spread from Colorectal Cancer Peritoneal Metastasis
11个月前
已关闭
Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases
11个月前
已完结
皖公网安备34019202002308
